| Financial Year |
March 31 2023 |
| Monetary Funds |
776,084,627.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,831,885,917.00 |
| Advances to Suppliers |
129,764,050.00 |
| Other Receivables |
212,113,436.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,905.00 |
| Dividend Receivable |
-- |
| Inventories |
2,410,186,920.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
740,044,021.00 |
| Total Current Assets |
6,108,627,183.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
386,043,737.00 |
| Long-term Equity Investment |
259,400,366.00 |
| Investment Properties |
-- |
| Fixed Assetes |
8,986,167,219.00 |
| Under-construction Projects |
626,858,301.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,141,450,009.00 |
| R&D expenses |
102,646,928.00 |
| Goodwill |
1,992,032,609.00 |
| Long-Term Deferred and Prepaid Expenses |
7,599,423.00 |
| Deferred Income Tax Assets |
133,355,265.00 |
| Other Non-Current Assets |
30,182,749.00 |
| Sub-Total of Non-Current Assets |
15,410,875,805.00 |
| Total Assets |
21,519,502,988.00 |
| Short-Term Loans |
1,089,651,435.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,577,742,437.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
478,705,736.00 |
| Taxes Payable |
160,542,621.00 |
| Interest Payable |
5,882,913.00 |
| Dividend Payable |
-- |
| Other payables |
465,612,315.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
216,754,683.00 |
| Other Current Liabilities |
3,579,346.00 |
| Sub-Total of Current Liabilities |
4,001,821,514.00 |
| Long-term Loans |
648,960,168.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,851,250.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
342,771,383.00 |
| Deferred Income Tax Liabilities |
767,646,139.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,501,488,431.00 |
| Total Liabilities |
6,503,309,945.00 |
| Paid-In Capital(Or Share Stock) |
2,681,901,273.00 |
| Capital Surplus |
1,004,724,976.00 |
| Surplus Reserve |
597,195,660.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
11,551,038,790.00 |
| Minority Stockholder's Interest |
19,314,037.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
14,996,879,006.00 |
| Owner's Equity（Stockholder's Equity） |
15,016,193,043.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,519,502,988.00 |
